Hocus POCUS: a tool for increasing the efficiency of diagnosing venous thromboembolic disease in critically ill COVID-19 patients?
Recruiting
- Conditions
- Pulmonary embolism, deep venous thrombosis, venous thromboembolic disease, COVID-19
- Registration Number
- NL-OMON22592
- Lead Sponsor
- MC Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
All patients with PCR confirmed COVID-19 with a clinically suspected pulmonary embolism, aged 18 years or over.
Exclusion Criteria
chronic and known deep vein thrombosis (DVT), ipsi- or contralateral DVT within the previous 6 months, pregnancy
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients.
- Secondary Outcome Measures
Name Time Method The percentage of preventable CTPA in the work up of suspected PE in COVID-19 positive patients. This percentage will be correlated to clinical parameters such as admission ward and early warning score.